Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-772315
Filing Date
2016-11-18
Accepted
2016-11-18 16:22:32
Documents
7
Period of Report
2016-11-18

Document Format Files

Seq Description Document Type Size
1 6-K d291811d6k.htm 6-K 14589
2 EX-99.1 d291811dex991.htm EX-99.1 16769
3 EX-99.2 d291811dex992.htm EX-99.2 11315
4 EX-99.3 d291811dex993.htm EX-99.3 22013
5 EX-99.4 d291811dex994.htm EX-99.4 19123
6 GRAPHIC g291811img1.jpg GRAPHIC 9863
7 GRAPHIC g291811img2.jpg GRAPHIC 25448
  Complete submission text file 0001193125-16-772315.txt   133856
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 162008025
SIC: 2834 Pharmaceutical Preparations